Masaya Tsuboi
Overview
Explore the profile of Masaya Tsuboi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
53
Citations
358
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Nagao I, Motegi T, Goto-Koshino Y, Tsuboi M, Takahashi N, Chambers J, et al.
J Vet Intern Med
. 2024 Nov;
38(6):3031-3037.
PMID: 39529599
Background: Gallbladder mucocele (GBM) is a common disease in the canine gallbladder. Although the pathogenesis of GBM remains unclear, we recently reported that the excessive accumulation of mucin in the...
2.
Eto S, Kato D, Saeki K, Iguchi T, Shiyu Q, Kamoto S, et al.
Vet Comp Oncol
. 2024 Aug;
22(4):500-512.
PMID: 39179510
A comprehensive understanding of the tumour immune microenvironment (TIME) is essential for advancing precision medicine and identifying potential therapeutic targets. This study focused on canine urothelial carcinoma (cUC) recognised for...
3.
Fujita N, Sugiyama F, Tsuboi M, Nakamura H, Nishimura R, Nakayama Y, et al.
Bioengineering (Basel)
. 2024 Jun;
11(6).
PMID: 38927851
Urinary tract diseases are common in cats, and often require surgical reconstruction. Here, to explore the possibility of urinary tract reconstruction in cats using in-body tissue architecture (iBTA), biosheets fabricated...
4.
Eto S, Shinada M, Saeki K, Tsuboi M, Kamoto S, Yoshitake R, et al.
Vet J
. 2024 Jan;
304:106064.
PMID: 38242282
Cyclooxgenase-2 (COX-2) is associated with inflammatory microenvironment and tumour progression. COX-2 expression was reported in canine tumours, and anti-COX treatment showed therapeutic effects in selected tumour types. Currently, direct comparisons...
5.
Nagao I, Tsuji K, Goto-Koshino Y, Tsuboi M, Chambers J, Uchida K, et al.
J Vet Med Sci
. 2023 Oct;
85(12):1269-1276.
PMID: 37899236
Gallbladder mucocele (GBM) is one of the most common gallbladder diseases in dogs. Its pathogenesis has not yet been clarified, but excessive accumulation of a secretory gel-forming mucin, MUC5AC in...
6.
Shinada M, Kato D, Tsuboi M, Ikeda N, Aoki S, Iguchi T, et al.
J Vet Med Sci
. 2023 Aug;
85(10):1068-1073.
PMID: 37544715
Podoplanin (PDPN) is a prognostic factor and is involved in several mechanisms of tumor progression in human squamous cell carcinoma (SCC). Canine non-tonsillar SCC (NTSCC) is a common oral tumor...
7.
Shinada M, Kato D, Motegi T, Tsuboi M, Ikeda N, Aoki S, et al.
Mol Cancer Res
. 2023 Jul;
21(11):1205-1219.
PMID: 37493578
Implications: Podoplanin could be a new therapeutic target to restrict the metastatic dissemination of canine and human mucosal melanoma.
8.
Asada H, Tani A, Sakuma H, Hirabayashi M, Matsumoto Y, Watanabe K, et al.
Sci Rep
. 2023 May;
13(1):8512.
PMID: 37231193
Histiocytic sarcoma (HS) is an incurable aggressive tumor, and no consensus has been made on the treatment due to its rare occurrence. Since dogs spontaneously develop the disease and several...
9.
Uchida M, Matsumiya Y, Tsuboi M, Uchida K, Nakagawa T, Fujii W, et al.
Vet Comp Oncol
. 2023 Apr;
21(3):391-400.
PMID: 37088561
Histiocytic sarcoma (HS) is a rare neoplasm of macrophages or dendritic cells with a poor prognosis in dogs. As the apoptosis inhibitor of macrophage (AIM) is characteristically expressed in canine...
10.
Ohmi A, Tanaka M, Rinno J, Tsuboi M, Chambers J, Uchida K, et al.
Vet Med Sci
. 2022 Nov;
9(2):609-617.
PMID: 36401603
Background: Lymphoma with Mott cell change, or Mott cell lymphoma (MCL), is an uncommon variant of canine lymphoma. Because of its rare occurrence, there has been no comprehensive study describing...